Research Letters Principal and main co-investigators in the ATAC Trial Web Appendix Argentina—Dr F Coppola, Dr C Bas: Hospital Aleman, Capital Federal, Buenos Aires; Dr J Itala, Dr G Cortese: Hospital de Clinicas, Buenos The ATAC Trialists group Aires University, Capital Federal, Buenos Aires; Dr A Nuñez de Pierro, Steering Committee Membership Dr D Allemand: Hospital General de Agudos-Juan Fernandez, Capital Professor A Howell (Chairman): Christie Hospital, Manchester, UK; Federal, Buenos Aires; Dr H Guixa, Dr R Testa: Hospital Italiano, Professor Judith Adams: University of Manchester, Manchester, UK; Capital Federal, Buenos Aires; Dr J Lebron, University of Buenos Aires, Professor M Baum: University College London (UCL), London, UK; Capital Federal, Buenos Aires; Australia—Professor G Gill, Dr J Kollias: Professor AR Bianco: Universita Degli Studi Di Napoli Federico II, Royal Adelaide Hospital, Adelaide, SA; Dr J Chirgwin, Dr M Leyden: Napoli Italy; Dr A Buzdar (Vice Chairman): The University of Texas, MD Box Hill Hospital, Box Hill, VIC; Dr J Beith, Dr A Sullivan: Royal Prince Anderson Cancer Center, Houston, USA; Professor D Cella: Albert Hospital, Camperdown, NSW; Dr S Della-Fiorentina, Northwestern University, Evanston, Illinois, USA; Dr M Coibion: Dr A Goldrick: Liverpool Hospital, Liverpool, NSW; Dr J Chirgwin, Institut Bordet, Bruxelles, Belgium; Professor R Coleman: Cancer Maroondah Hospital, Maroondah, VIC; Research Centre, Weston Park Hospital, Sheffield, UK; Associate Professor G Richardson, Dr S Hart: Monash Medical Centre, Dr M Constenla: Hospital Montecelo, Pontevedra, Spain; Melbourne, VIC; Associate Professor G Toner, Dr P Francis: Professor J Cuzick (Independent Statistician): Cancer Research UK, Peter MacCallum Cancer Institute, East Melbourne, VIC; Dr R Snyder, London, UK; Professor Dr W Distler: Frauenklinik Carl Gustav Carus Dr I Burns: St Vincents Hospital, Melbourne, VIC; Universität Dresden, Dresden, Germany; Professor M Dowsett: The Royal Professor M Friedlander, Dr D Goldstein: Prince of Wales Hospital, Marsden Hospital, London, UK; Mr S Duffy: St James’s University Randwick, NSW; Professor J Forbes, Dr D Jackson: University of Hospital, Leeds, UK; Professor R Eastell: University of Sheffield, Newcastle, Newcastle Mater Misericordiae Hospital, Waratah, NSW; Sheffield, UK; Professor LJ Fallowfield, University of Sussex, Brighton, Belgium—Dr A Makar, Dr D Van den Weyngaert: AZ Middelheim, UK; Professor J Forbes: Newcastle Mater Misericordiae Hospital, NSW, Antwerpen; Professor D Gangji, Dr T Velu: Hôpital Erasme, Brussels; Australia; Professor WD George: Beatson Oncology Centre, Western Dr M Coibion, Dr J-M Nogaret: Institut Bordet, Brussels; Dr P Neven, Infirmary, Glasgow, UK; Sr J Gray: Belfast City Hospital, Belfast, UK; Dr Laurent: St Jan Ziekenhuis, Brussels; Dr J De Mol, Dr F Van Aelst: Dr J-P Guastalla: Centre Léon Bérard, Lyon, France; Mr R Hellmund, Heilig Hart Ziekenhuis, Roeselare; Canada—Dr SR Sehdev MD: Dr G Hoctin-Boes: AstraZeneca Pharmaceuticals, Wilmington, USA; Queen Lynch Medical Centre, Brampton, Ontario; Dr R Simard: Mrs J Houghton(Trial Secretary), Dr N Williams: Clinical Trials Group of Complexe Hospitalier de la Sagami, Chicoutimi, Québec; J Mackey MD, the Department of Surgery, UCL, London, UK; Professor Dr JGM Klijn: Cross Cancer Institute, Edmonton, Alberta; Dr J Dufresne MD: Dr. Daniel den Hoed Kliniek and University Hospital, Rotterdam, CHUS Hospital Fleurimont, Fleurimont, Québec; Dr WS Lofters: Rotterdam, The Netherlands; Dr GY Locker: Evanston Northwestern Kingston Regional Cancer Center, Kingston, Ontario; Dr DR Holland: Healthcare, Northwestern University Feinberg School of Medicine, Lethbridge Cancer Centre, Lethbridge, Alberta; Dr HL Solow: Markham Evanston, IL, USA; Dr J Mackey: Cross Cancer Institute, Edmonton, Stouffville Health Centre, Markham, Ontario; Dr JA Gapski: Trillium Alberta, Canada; Professor RE Mansel: University of Wales College of Health Centre, Mississauga, Ontario; Dr SH Rubin: South East Health Medicine, Cardiff, UK; Professor JM Nabholtz: Hartman Oncology Care Oncology Department, Moncton Hospital, Moncton, New Institute, Levallois-Perret, France; Dr T Nagykalnai: Uzsoki U Hospital, Brunswick; Dr A Robidoux: CHUM Campus Hotel-Dieu, Montreal, Budapest, Hungary; Dr A Nicolucci: Givio Co-ordinating Centre, Québec; B L’Esperance MD: Hôpital du Sacre-Coeur de Montreal, Consorzio Mario Negri Sud, Centro Di Ricerchi Farmacologichi, Québec; Dr LC Panasci: McGill Department of Oncology, Montreal, E Biomedichi, Chieta, Italy; Dr U Nylen: Radiumhemmet, Karolinska Québec; Dr LA Zibdawi MD: Southlake Regional Health Centre, Sjukhuset, Stockholm, Sweden; Mr R Sainsbury: University College Newmarket, Ontario; Dr J Chang: Lakeridge Health, Oshawa, Ontario; London (UCL), London, UK; Dr F Sapunar, Dr VJ Suarez-Mendez: Dr S Arif MD: Penticton Regional Hospital, Penticton, British AstraZeneca Pharmaceuticals, Macclesfield, UK; Professor JS Tobias: Columbia; Dr RF Wierzbicki: Peterborough Regional Health Center The Meyerstein Institute of Clinical Oncology, Middlesex Hospital, Oncology Clinic, Peterborough, Ontario; Dr BP Findlay: Hotel Dieu London, UK. Hospital Oncology Department, Québec City, Québec; Dr J Robert, International Project Team CHAUQ-Hospital du St-Sacrement, Québec City, Québec; Dr S Lebel: A Doe, Dr F Sapunar, Dr VJ Suarez-Mendez: AstraZeneca Hospital Laval, Québec City, Québec; Dr M Jancewicz: Allan Blair Pharmaceuticals, Macclesfield, UK; E Foster: ISD Cancer Clinical Cancer Center, Regina, Saskatchewan; Dr MJ Burnell: Atlantic Health Trials Team, Edinburgh, UK; J Houghton, N Williams: Clinical Trials Sciences Corp, Saint John, New Brunswick; Dr A Sami: Saskatoon Group of the Department of Surgery, UCL, London, UK; A Nicolucci: Cancer Centre, Saskatoon, Saskatchewan; Dr PLD Walde: Algoma Mario Negri Institute, Chieta, Italy; S Pollard: Clinical Trials Research Regional Cancer Program, Sault Ste Marie, Ontario; Dr PK Ganguly: Unit, Leeds, UK H Bliss Murphy Cancer Centre, St Johns, Newfoundland; Data Monitoring Committee Dr CJ Germond MD: Northeastern Ontario Regional Cancer Center, Dr M Buyse: International Institute for Drug Development (IDDI), Sudbury, Ontario; Dr Y Rahim: Toronto East General Hospital, Toronto, Brussels, Belgium; Professor J Cuzick (Independent statistician), Ontario; Dr JJ Wilson: Humber River Regional Hospital, Weston, Mr C Wale: Cancer Research UK, London, UK; Dr R Margolese: McGill Ontario; Dr AL Cooke: Manitoba Cancer Treatment and Research University, The Sir Mortimer B Davis Jewish General Hospital, Montreal, Foundation, Winnipeg, Manitoba; Czech Republic—Dr K Petrakova, Québec, Canada; Professor JJ Body: Institute J Bordet, Bruxelles, Dr R Demlova: Masarykuv onkologicky ustav, Brno; Dr P Vodvarka, Belgium. Dr T Kysela: FNsP Ostrava, Ostrava Poruba; Dr B Konopasek, Collaborative/Operational Groups Dr P Mares: Vseobecna fakultni nemocnice, Praha; France— JF Forbes (Group Co-ordinator), JK Wakeham (Study Coordinator): Professor J-E Mention: Centre de Gyneco-Obst, CHU, Amiens; Australian New Zealand Breast Cancer Trials Group Operations Office; Dr D Serin, Dr Y Goubely-Brewer: Clinique Ste Catherine, Avignon; S de Placido (Study Co-ordinator), C Carlomagno (Study Co-ordinator): Professor J-P Labat, Dr J-P Malhaire: CHU Brest, Brest; Dr G Devulder, Universita Degli Studi Di Napoli Federico II, Italy; A Nicolucci (Group Dr S Mirdat-Dako: Centre Hospitalier Laënnec, Creil; Co-ordinator), M Belfiglio (Study Co-ordinator), M Valentini (Study Professor JM Nabholtz: Hartman Oncology Institute, Levallois-Perret, Co-ordinator): GIVIO Group, Consorzio Mario Negri Sud, Italy; France; Professor D Houze De L’Aunoit, Dr J-Y Charvolin: Hôpital E Foster (Principal Trial Co-ordinator and CCTT contact): ISD Cancer St Philibert, Lomme; Dr J-P Guastalla, Dr J Guastalla: Centre Léon Clinical Trials Team, Edinburgh, UK, [email protected]; Bérard, Lyon; Dr R Coquard, Dr B Velay: Clinique St Jean, Lyon; S Pollard (Head of Pharmaceutical Collaboration): Clinical Trials Dr C Lejeune, Dr D Hadjadj-Aoul: Hôpital de la Conception, Marseille; Research Unit, University of Leeds, Leeds, UK; J Houghton (Senior Dr M Untereiner: Hôpital-Clinique Claude Bernard, Metz; Lecturer in Clinical Trials and CTG contact), N Williams (Trial Co- Professor PI Laffargue, Hôpital Arnaud de Villeneuve, Montpellier; ordinator): Clinical Trials Group of the Department of Surgery, UCL, Dr M Rios: Centre Alexis Vautrin, Nancy; Dr J-M Vannetzel, London, UK, [email protected]. Dr R Mahjoubi: Centre Chirurgical Henri Hartmann, Neuilly sur Seine; www.thelancet.com Published online December 8, 2004 http://image.thelancet.com/extras/04let11120webappendix.pdf 1 For personal use. Only reproduce with permission from Elsevier Ltd. Research Letters Dr R Samak: Cabinet Medical, Nice; Dr F Morvan, Dr F Rousseau: Professor O de Carlos: Hospitais da Universidade de Coimbra, Centre Hospitalier, Pontoise; Dr C Veyret, Dr JP Julien: Centre Henri Coimbra, Portugal; Dr O Candeias, Dr B da Costa: Hospital de Sta. Becquerel, Rouen; Dr P Quetin: Centre Paul Strauss, Strasbourg; Maria, Lisboa; Dr RA Alves Dias dos reis: Hospital de S. Joao, Porto, Professor J-P Brettes, Dr C Mathelin: Hôpital Civil, Strasbourg; Portugal; Dr A Alcazar: Hospital Reynaldo dos Santos, Vila Franca de Germany—Professor Dr W Distler, Dr A Schindelhauer: Frauenklinik Xira, Portugal; Slovak Republic—Professor S Spanik, Dr I Vochyanova: Carl Gustav Carus Universität Dresden; Professor MW Beckmann, Onkologicky